首页> 外国专利> HUMAN MONOCLONAL ANTIBODIES DERIVED FROM HUMAN B CELLS AND HAVING NEUTRALIZING ACTIVITY AGAINST INFLUENZA A VIRUSES.

HUMAN MONOCLONAL ANTIBODIES DERIVED FROM HUMAN B CELLS AND HAVING NEUTRALIZING ACTIVITY AGAINST INFLUENZA A VIRUSES.

机译:源自人类B细胞的人类单克隆抗体,并且具有针对流感病毒的中和活性。

摘要

The present invention relates to human monoclonal antibodies derived from human B cells present in the blood of patients who had recovered from infection with influenza A viruses, wherein the monoclonal antibodies have neutralizing activity against influenza A viruses. The anti-influenza A virus monoclonal antibody of the present invention has binding and neutralizing activities against at least one influenza A virus selected from the group consisting of influenza A virus H1, H2 and H5 subtypes, and thus it is useful for the prevention and treatment of a disease caused by the influenza A virus and is also useful for diagnosis of influenza A virus infection. The present invention relates to human monoclonal antibodies derived from human B cells present in the blood of patients who had recovered from infection with influenza A viruses, wherein the monoclonal antibodies have neutralizing activity against influenza A viruses. The anti-influenza A virus monoclonal antibody of the present invention has binding and neutralizing activities against at least one influenza A virus selected from the group consisting of influenza A virus H1, H2 and H5 subtypes, and thus it is useful for the prevention and treatment of a disease caused by the influenza A virus and is also useful for diagnosis of influenza A virus infection. According to one embodiment of the present invention, disclosed is a method for determining an antenna in a terminal which includes a plurality of non-directional antennas. The antenna determination method may comprise the steps of: performing a measurement on a reference signal from one or more cells through the plurality of non-directional antennas at an initial state; selecting a cell on the basis of a measured value; selecting an antenna to be used for transmission and reception among the plurality of non-directional antennas on the basis of the measured value; monitoring whether or not a long-term timer has elapsed; and again performing the measurement step, the cell selection step, and the antenna selection step when the long-term timer has elapsed.
机译:本发明涉及衍生自从甲型流感病毒感染中恢复的患者血液中存在的人B细胞的人单克隆抗体,其中所述单克隆抗体具有针对甲型流感病毒的中和活性。本发明的抗甲型流感病毒单克隆抗体对至少一种选自甲型流感病毒H1,H2和H5亚型的甲型流感病毒具有结合和中和活性,因此可用于预防和治疗由甲型流感病毒引起的疾病的诊断,也可用于诊断甲型流感病毒感染。本发明涉及衍生自从甲型流感病毒感染中恢复的患者血液中存在的人B细胞的人单克隆抗体,其中所述单克隆抗体具有针对甲型流感病毒的中和活性。本发明的抗甲型流感病毒单克隆抗体对至少一种选自甲型流感病毒H1,H2和H5亚型的甲型流感病毒具有结合和中和活性,因此可用于预防和治疗由甲型流感病毒引起的疾病的诊断,也可用于诊断甲型流感病毒感染。根据本发明的一个实施例,公开了一种用于确定包括多个非定向天线的终端中的天线的方法。天线确定方法可以包括以下步骤:在初始状态下,通过多个非定向天线,对来自一个或多个小区的参考信号进行测量;根据测量值选择一个单元;根据测量值,在多个无方向性天线中选择要用于发送和接收的天线;监视是否已使用了长期计时器;当经过了长时间定时器后,再次执行测量步骤,小区选择步骤和天线选择步骤。

著录项

  • 公开/公告号MX2012010406A

    专利类型

  • 公开/公告日2012-10-03

    原文格式PDF

  • 申请/专利权人 CELLTRION INC.*;

    申请/专利号MX20120010406

  • 申请日2011-03-07

  • 分类号C07K16/10;C12N15/44;C12N15/63;G01N33/53;

  • 国家 MX

  • 入库时间 2022-08-21 17:23:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号